These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


316 related items for PubMed ID: 19782152

  • 1. Fine-tuning the lipogenic/lipolytic balance to optimize the metabolic requirements of cancer cell growth: molecular mechanisms and therapeutic perspectives.
    Menendez JA.
    Biochim Biophys Acta; 2010 Mar; 1801(3):381-91. PubMed ID: 19782152
    [Abstract] [Full Text] [Related]

  • 2. Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids?
    Menendez JA, Colomer R, Lupu R.
    Med Hypotheses; 2005 Mar; 64(2):342-9. PubMed ID: 15607569
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells.
    Vazquez-Martin A, Colomer R, Brunet J, Lupu R, Menendez JA.
    Cell Prolif; 2008 Feb; 41(1):59-85. PubMed ID: 18211286
    [Abstract] [Full Text] [Related]

  • 4. The mitochondrial H(+)-ATP synthase and the lipogenic switch: new core components of metabolic reprogramming in induced pluripotent stem (iPS) cells.
    Vazquez-Martin A, Corominas-Faja B, Cufi S, Vellon L, Oliveras-Ferraros C, Menendez OJ, Joven J, Lupu R, Menendez JA.
    Cell Cycle; 2013 Jan 15; 12(2):207-18. PubMed ID: 23287468
    [Abstract] [Full Text] [Related]

  • 5. Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids.
    Zaidi N, Lupien L, Kuemmerle NB, Kinlaw WB, Swinnen JV, Smans K.
    Prog Lipid Res; 2013 Oct 15; 52(4):585-9. PubMed ID: 24001676
    [Abstract] [Full Text] [Related]

  • 6. Increased lipogenesis in cancer cells: new players, novel targets.
    Swinnen JV, Brusselmans K, Verhoeven G.
    Curr Opin Clin Nutr Metab Care; 2006 Jul 15; 9(4):358-65. PubMed ID: 16778563
    [Abstract] [Full Text] [Related]

  • 7. Mediterranean dietary traditions for the molecular treatment of human cancer: anti-oncogenic actions of the main olive oil's monounsaturated fatty acid oleic acid (18:1n-9).
    Menendez JA, Lupu R.
    Curr Pharm Biotechnol; 2006 Dec 15; 7(6):495-502. PubMed ID: 17168666
    [Abstract] [Full Text] [Related]

  • 8. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
    Menendez JA, Ropero S, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Jun 15; 24(6):1369-83. PubMed ID: 15138577
    [Abstract] [Full Text] [Related]

  • 9. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 15; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of gamma-linolenic acid-induced toxicity to tumor cells: an extension to Nwankwo's hypothesis.
    Menendez JA, Colomer R, Lupu R.
    Med Hypotheses; 2005 Mar 15; 64(2):337-41. PubMed ID: 15607568
    [Abstract] [Full Text] [Related]

  • 11. Inhibiting adipose tissue lipogenesis reprograms thermogenesis and PPARγ activation to decrease diet-induced obesity.
    Lodhi IJ, Yin L, Jensen-Urstad AP, Funai K, Coleman T, Baird JH, El Ramahi MK, Razani B, Song H, Fu-Hsu F, Turk J, Semenkovich CF.
    Cell Metab; 2012 Aug 08; 16(2):189-201. PubMed ID: 22863804
    [Abstract] [Full Text] [Related]

  • 12. Peroxisome proliferator-activated receptor-gamma protects ERBB2-positive breast cancer cells from palmitate toxicity.
    Kourtidis A, Srinivasaiah R, Carkner RD, Brosnan MJ, Conklin DS.
    Breast Cancer Res; 2009 Aug 08; 11(2):R16. PubMed ID: 19298655
    [Abstract] [Full Text] [Related]

  • 13. Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer.
    Tomek K, Wagner R, Varga F, Singer CF, Karlic H, Grunt TW.
    Mol Cancer Res; 2011 Dec 08; 9(12):1767-79. PubMed ID: 21970855
    [Abstract] [Full Text] [Related]

  • 14. Clinical and therapeutic relevance of the metabolic oncogene fatty acid synthase in HER2+ breast cancer.
    Corominas-Faja B, Vellon L, Cuyàs E, Buxó M, Martin-Castillo B, Serra D, García J, Lupu R, Menendez JA.
    Histol Histopathol; 2017 Jul 08; 32(7):687-698. PubMed ID: 27714708
    [Abstract] [Full Text] [Related]

  • 15. Intermittent Hypoxia Stimulates Lipolysis, But Inhibits Differentiation and De Novo Lipogenesis in 3T3-L1 Cells.
    Musutova M, Weiszenstein M, Koc M, Polak J.
    Metab Syndr Relat Disord; 2020 Apr 08; 18(3):146-153. PubMed ID: 31928504
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological inhibitors of Fatty Acid Synthase (FASN)--catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents?
    Lupu R, Menendez JA.
    Curr Pharm Biotechnol; 2006 Dec 08; 7(6):483-93. PubMed ID: 17168665
    [Abstract] [Full Text] [Related]

  • 17. Does endogenous fatty acid metabolism allow cancer cells to sense hypoxia and mediate hypoxic vasodilatation? Characterization of a novel molecular connection between fatty acid synthase (FAS) and hypoxia-inducible factor-1alpha (HIF-1alpha)-related expression of vascular endothelial growth factor (VEGF) in cancer cells overexpressing her-2/neu oncogene.
    Menendez JA, Vellon L, Oza BP, Lupu R.
    J Cell Biochem; 2005 Apr 01; 94(5):857-63. PubMed ID: 15669079
    [Abstract] [Full Text] [Related]

  • 18. Fatty Acids and Breast Cancer: Make Them on Site or Have Them Delivered.
    Kinlaw WB, Baures PW, Lupien LE, Davis WL, Kuemmerle NB.
    J Cell Physiol; 2016 Oct 01; 231(10):2128-41. PubMed ID: 26844415
    [Abstract] [Full Text] [Related]

  • 19. Fatty acid synthase plays a role in cancer metabolism beyond providing fatty acids for phospholipid synthesis or sustaining elevations in glycolytic activity.
    Hopperton KE, Duncan RE, Bazinet RP, Archer MC.
    Exp Cell Res; 2014 Jan 15; 320(2):302-10. PubMed ID: 24200503
    [Abstract] [Full Text] [Related]

  • 20. Targeting fatty acid synthase-driven lipid rafts: a novel strategy to overcome trastuzumab resistance in breast cancer cells.
    Menendez JA, Vellon L, Lupu R.
    Med Hypotheses; 2005 Jan 15; 64(5):997-1001. PubMed ID: 15780499
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.